Weiru Chi

598 total citations
28 papers, 434 citations indexed

About

Weiru Chi is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Weiru Chi has authored 28 papers receiving a total of 434 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Cancer Research, 11 papers in Molecular Biology and 9 papers in Oncology. Recurrent topics in Weiru Chi's work include Breast Cancer Treatment Studies (11 papers), HER2/EGFR in Cancer Research (6 papers) and Cancer-related molecular mechanisms research (6 papers). Weiru Chi is often cited by papers focused on Breast Cancer Treatment Studies (11 papers), HER2/EGFR in Cancer Research (6 papers) and Cancer-related molecular mechanisms research (6 papers). Weiru Chi collaborates with scholars based in China, Switzerland and United States. Weiru Chi's co-authors include Jiong Wu, Bingqiu Xiu, Rong Guo, Yayun Chi, Lun Li, Jingyan Xue, Yonghui Su, Jing Si, Shenglin Huang and Jiajian Chen and has published in prestigious journals such as Cancer, Cancer Research and International Journal of Molecular Sciences.

In The Last Decade

Weiru Chi

26 papers receiving 432 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weiru Chi China 9 290 221 124 80 43 28 434
Yongchen Liu China 9 142 0.5× 184 0.8× 77 0.6× 41 0.5× 18 0.4× 17 302
Qijue Lu China 11 226 0.8× 342 1.5× 62 0.5× 69 0.9× 13 0.3× 22 451
Xiaping Wang China 9 183 0.6× 164 0.7× 46 0.4× 102 1.3× 12 0.3× 20 330
Hao Dang Netherlands 10 111 0.4× 141 0.6× 66 0.5× 148 1.9× 31 0.7× 27 330
Zeng-Hong Li Hong Kong 13 196 0.7× 226 1.0× 37 0.3× 53 0.7× 16 0.4× 13 341
Yoshiko Mori Japan 12 105 0.4× 165 0.7× 79 0.6× 159 2.0× 102 2.4× 44 400
Alba Martínez United States 6 112 0.4× 121 0.5× 35 0.3× 77 1.0× 28 0.7× 10 287
Vanessa de Luque Spain 9 164 0.6× 135 0.6× 31 0.3× 145 1.8× 39 0.9× 18 319
Jessica Consiglio Italy 5 187 0.6× 267 1.2× 25 0.2× 57 0.7× 27 0.6× 7 359

Countries citing papers authored by Weiru Chi

Since Specialization
Citations

This map shows the geographic impact of Weiru Chi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiru Chi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiru Chi more than expected).

Fields of papers citing papers by Weiru Chi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weiru Chi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiru Chi. The network helps show where Weiru Chi may publish in the future.

Co-authorship network of co-authors of Weiru Chi

This figure shows the co-authorship network connecting the top 25 collaborators of Weiru Chi. A scholar is included among the top collaborators of Weiru Chi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weiru Chi. Weiru Chi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Qi, Yi Zhang, Li-Yi Zhang, et al.. (2025). LINC01235 Promotes Clonal Evolution through DNA Replication Licensing‐Induced Chromosomal Instability in Breast Cancer. Advanced Science. 12(14). e2413527–e2413527. 1 indexed citations
2.
Chi, Weiru, Bingqiu Xiu, Qi Zhang, et al.. (2025). PPARG Activation of Fatty Acid Metabolism Drives Resistance to Anti-HER2 Therapies in HER2-Positive Breast Cancer. International Journal of Biological Sciences. 21(6). 2396–2414. 3 indexed citations
3.
Chi, Weiru, Yuwei Ma, Qí Zhāng, et al.. (2024). DUSP4 enhances therapeutic sensitivity in HER2-positive breast cancer by inhibiting the G6PD pathway and ROS metabolism by interacting with ALDOB. Translational Oncology. 46. 102016–102016. 3 indexed citations
4.
5.
Zheng, Shuyue, Benlong Yang, Lun Li, et al.. (2024). CRTAM promotes antitumor immune response in triple negative breast cancer by enhancing CD8+ T cell infiltration. International Immunopharmacology. 129. 111625–111625. 4 indexed citations
6.
Chi, Weiru, Bingqiu Xiu, Pei Li, et al.. (2023). MNX1 Promotes Anti-HER2 Therapy Sensitivity via Transcriptional Regulation of CD-M6PR in HER2-Positive Breast Cancer. International Journal of Molecular Sciences. 25(1). 221–221. 2 indexed citations
7.
Chi, Weiru, Qi Zhang, Lun Li, et al.. (2023). Immediate Breast Reconstruction After Neoadjuvant Chemotherapy. Annals of Plastic Surgery. 91(1). 48–54. 2 indexed citations
8.
Si, Jing, Rong Guo, Bingqiu Xiu, et al.. (2022). Stabilization of CCDC102B by Loss of RACK1 Through the CMA Pathway Promotes Breast Cancer Metastasis via Activation of the NF-κB Pathway. Frontiers in Oncology. 12. 927358–927358. 8 indexed citations
9.
Ye, Fangdie, Min Xiong, Bingqiu Xiu, et al.. (2022). Cross-talk of four types of RNA modification proteins with adenosine reveals the landscape of multivariate prognostic patterns in breast cancer. Frontiers in Genetics. 13. 943378–943378. 3 indexed citations
10.
Chen, Ming, et al.. (2022). The Prognostic Values of Androgen Receptor in Breast Cancer. Archives of Pathology & Laboratory Medicine. 147(9). 1075–1085. 3 indexed citations
11.
Sang, Yuting, Weiru Chi, Jiajian Chen, et al.. (2022). Surgical options of the breast and clinical outcomes of breast cancer patients after neoadjuvant chemotherapy: A single-center retrospective study. Frontiers in Oncology. 12. 984587–984587. 6 indexed citations
12.
13.
Su, Yonghui, Yuchen Li, Rong Guo, et al.. (2021). Plasma extracellular vesicle long RNA profiles in the diagnosis and prediction of treatment response for breast cancer. npj Breast Cancer. 7(1). 154–154. 31 indexed citations
14.
15.
Wang, Jia, Bingqiu Xiu, Rong Guo, et al.. (2020). Autologous tissue reconstruction after mastectomy–A cross-sectional survey of 110 hospitals in China. European Journal of Surgical Oncology. 46(12). 2202–2207. 5 indexed citations
16.
Li, Lun, Yonghui Su, Bingqiu Xiu, et al.. (2019). Comparison of prepectoral and subpectoral breast reconstruction after mastectomies: A systematic review and meta analysis. European Journal of Surgical Oncology. 45(9). 1542–1550. 76 indexed citations
17.
Si, Jing, Rong Guo, Naisi Huang, et al.. (2019). Axillary evaluation is not warranted in patients preoperatively diagnosed with ductal carcinoma in situ by core needle biopsy. Cancer Medicine. 8(18). 7586–7593. 2 indexed citations
18.
Huang, Sheng, Yayun Chi, Weiru Chi, et al.. (2019). LINC00309 is associated with short disease-free survival in breast cancer. Cancer Cell International. 19(1). 210–210. 3 indexed citations
19.
Xiu, Bingqiu, Yayun Chi, Lei Liu, et al.. (2019). LINC02273 drives breast cancer metastasis by epigenetically increasing AGR2 transcription. Molecular Cancer. 18(1). 187–187. 169 indexed citations
20.
Guo, Rong, Jing Si, Yonghui Su, et al.. (2019). Changing patterns and survival improvements of young breast cancer in China and SEER database, 1999−2017. Chinese Journal of Cancer Research. 31(4). 653–662. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yongchen Liu Breakdown of academic impact, for papers by Qijue Lu Breakdown of academic impact, for papers by Xiaping Wang Breakdown of academic impact, for papers by Hao Dang Breakdown of academic impact, for papers by Zeng-Hong Li Breakdown of academic impact, for papers by Yoshiko Mori Breakdown of academic impact, for papers by Alba Martínez Breakdown of academic impact, for papers by Vanessa de Luque Breakdown of academic impact, for papers by Jessica Consiglio
Rankless by CCL
2026